CIK 0001919246
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 863335449
- Phone
- +1 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-25 | Friedberg Ezra M Director | Sale | −5,999 | $28.00 | $168K | 34,001 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −2,000 | $28.14 | $56K | 32,001 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −1 | $28.50 | $29 | 32,000 |
| 2025-11-25 | Friedberg Ezra M Director | Sale | −2,000 | $28.01 | $56K | 30,000 |
Page 2 of 2 · 24 trades